In this issue:
6 vs 12 months of DAPT after drugeluting stent implantation for STEMI
Statin use in the elderly
Diclofenac and CV risk
Aspirin for primary prevention in the elderly
Rivaroxaban in patients with heart failure and CAD
Wearable cardioverter-defibrillator after MI
Tafamidis for the treatment of transthyretin amyloid cardiomyopathy
Albiglutide in type 2 diabetics with CV disease
Lipoprotein(a) levels for prediction of CV events
Long-term mortality in ASCOT trial participants
Please login below to download this issue (PDF)